Showing 8,421 - 8,440 results of 104,764 for search '(( i wt decrease ) OR ( 5 ((((point decrease) OR (fold decrease))) OR (a decrease)) ))', query time: 1.61s Refine Results
  1. 8421

    Massachusetts Medicaid members that smoked in 2008: Characteristics associated with smoking status in 2014 by Alexis D. Henry (4509955)

    Published 2017
    “…The 2014 survey included an open ended-question asking members “what helped the most” in quitting or quit attempts. We observed a significant decrease in members reporting smoking “every/some days” of 15.5 percentage points (p < .0001) from 2008 to 2014, and a significant decrease in smokers reporting smoking “more than 10 cigarettes on days smoked” of 16.7 percentage points (p < .0001). …”
  2. 8422

    Relationships between empty body lipid weight decrease and corrected amounts of pollutants excreted through faeces (faecal output–feed input) for TCDD (○, ●), and PCBs 153 (□, ■) and 126 (Δ, ▲) over a 57-day depuration period in ewes receiving a control well-fed and non-supplemented treatments (CTL: ○, □, Δ; <i>n</i> = 4), or an underfed and mineral oil supplemented treatment (UFMO: ●, ■, ▲; <i>n</i> = 5). by Sylvain Lerch (1494349)

    Published 2020
    “…<p>Relationships between empty body lipid weight decrease and corrected amounts of pollutants excreted through faeces (faecal output–feed input) for TCDD (○, ●), and PCBs 153 (□, ■) and 126 (Δ, ▲) over a 57-day depuration period in ewes receiving a control well-fed and non-supplemented treatments (CTL: ○, □, Δ; <i>n</i> = 4), or an underfed and mineral oil supplemented treatment (UFMO: ●, ■, ▲; <i>n</i> = 5).…”
  3. 8423
  4. 8424

    PowerPoint Slides for: Effect of Febuxostat on the Endothelial Dysfunction in Hemodialysis Patients: A Randomized, Placebo-Controlled, Double-Blinded Study by Alshahawey M. (4032740)

    Published 2017
    “…Treatment with febuxostat resulted in a significant decrease in the serum ADMA level from 1.027 ± 0.116 to 0.944 ± 0.104 µmol/L and the serum hsCRP level from 12.5 ± 1.65 to 12.1 ± 1.70 mg/L. …”
  5. 8425
  6. 8426
  7. 8427
  8. 8428
  9. 8429
  10. 8430
  11. 8431
  12. 8432
  13. 8433
  14. 8434

    Representative diagram shows the impact of TXNIP deletion on retina vasculature under both normoxia and hyperoxia. by Mohammed A. Abdelsaid (287140)

    Published 2014
    “…Retinas from TKO although showed less peroxynitrite levels and maintained Akt activation, retinas experienced significant decreases in thioredoxin (Trx) that shift the balance of the ASK-1-Trx inhibitory complex and increases the activation of the proapoptotic ASK-1 pathway leading to exacerbated vasoobliteration compared to WT.…”
  15. 8435

    A mt-tRNA<sup>Ser(UCN)</sup> point mutation, m.7480A>G, impairs i<sup>6</sup>A37 modification. by John W. Yarham (573109)

    Published 2014
    “…<b>B</b>) The i<sup>6</sup>A modification of position 37 is decreased (stronger binding of the mt-tRNA<sup>Ser(UCN)</sup> double ACL probe) by ∼86% in patient skeletal muscle relative to control muscle. …”
  16. 8436
  17. 8437

    MyD88-dependent inflammasome activation and autophagy inhibition contributes to <i>Ehrlichia</i>-induced liver injury and toxic shock by Muhamuda Kader (437247)

    Published 2017
    “…To address this issue, we compared susceptibility to lethal <i>Ixodes ovatus Ehrlichia</i> (IOE) infection between wild type (WT) and MyD88-deficient (MyD88<sup>-/-</sup>) mice. …”
  18. 8438
  19. 8439

    Impaired fibronectin and fibrinogen-cleaving activities of the E143A and H146A Zmp1 mutants. by Valeria Cafardi (490077)

    Published 2013
    “…(<b>C</b>) Decreased ability of E143A and H146A Zmp1 mutants to cleave fibronectin. 1 µM fibronectin from human plasma was incubated for 24 h at 37°C with no Zmp1 (control) or with 7.7 µM of wild type (WT), E143A or H146A Zmp1 in the presence of 0.5 mM ZnCl<sub>2</sub>. 1 µg of fibronectin was analyzed by SDS-PAGE and Coomassie-blue staining. …”
  20. 8440